We show that non-Abelian discrete symmetries in orbifold string models have a gauge origin. This can be understood when looking at the vicinity of a symmetry enhanced point in moduli space. At such an enhanced point, orbifold fixed points are characterized by an enhanced gauge symmetry. This gauge symmetry can be broken to a discrete subgroup by a nontrivial vacuum expectation value of the Kahler modulus T. Using this mechanism it is shown that the Delta (54) non-Abelian discrete symmetry group originates from a SU(3) gauge symmetry, whereas the D-4 symmetry group is obtained from a SU(2) gauge symmetry
We study heterotic asymmetric orbifold models. By utilizing the lattice engineering technique, we classify (22,6)-dimensional Narain lattices with right-moving non-Abelian group factors which can be starting points for Z 3 asymmetric orbifold construction. We also calculate gauge symmetry breaking patterns.
Using Z 3 asymmetric orbifolds in heterotic string theory, we construct N = 1 SUSY three-generation models with the standard model gauge group SU(3) C × SU(2) L × U(1) Y and the left-right symmetric group SU(3)One of the models possesses a gauge flavor symmetry for the Z 3 twisted matter.
We investigate a gauge theory realization of non-Abelian discrete flavor symmetries and apply the gauge enhancement mechanism in heterotic orbifold models to fieldtheoretical model building. Several phenomenologically interesting non-Abelian discrete symmetries are realized effectively from a U (1) gauge theory with a permutation symmetry. We also construct a concrete model for the lepton sector based on a U (1) 2 ⋊ S 3 symmetry.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.